http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0067615-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-04 |
| filingDate | 1982-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19149901332884dcba1655f582bc0b7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_749715c47bc48376ca056b5001d50a26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_822fc7f67eb73cbc30576737e6ff533d |
| publicationDate | 1982-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0067615-A1 |
| titleOfInvention | Alkylthio derivatives of azabicyclobenzamides, their preparation and pharmaceutical compositions |
| abstract | Pharmaceutical compositions comprising compounds of formula (I) or pharmaceutically acceptable salts and/or N-oxides and/or solvates thereof:n wherein:n R 1 is a C 1-6 alkoxy or C 1-6 alkylthio group; and one of R 2 , R 3 and R 4 is hydrogen, the second is C 1-6 alkylthio and the third is selected from the class of substituents consisting of hydrogen, halogen, CF 3 , C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, C 1-7 acyl, C 1-7 acylamino, C 1-6 alkylsulphonyl, C 1-6 alkylsulphinyl, hydroxy, nitro or amino, aminocarbonyl or aminosulphonyl optionally N-substituted by one or two C 1-6 alkyl groups; or R 1 is joined to R 2 to form C 1-2 alkylenedioxy; and one of R 3 and R 4 is C 1-6 alkylthio and the other is selected from the class of substituents defined above; R 5 is hydrogen or C 1-6 alkyl; R 6 is C 1-7 alkyl or a group -(CH 2 ) s R 7 where s is 0 to 2 and R 7 is a C 3-8 cycloalkyl group, or a group -(CH 2 ) R a where t is 1 or 2 and R 8 is C 2-5 alkenyl or a phenyl group optionally substituted by one or two substituents selected from C 1-6 alkyl, C 1-4 alkoxy, trifluoromethyl and halogen, or a thienyl group; and p and q are independently 0 to 2 and a pharmaceutically acceptable carrier, novel compounds within formula (I) having useful pharmacological activity and a process for their preparation. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0220011-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5240957-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0093488-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0220011-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4816453-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0227215-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5011992-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0095262-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0093488-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820715-A |
| priorityDate | 1981-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.